CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells

Stem Cells

Volumn 27, Issue 12, 2009, Pages 2928-2940

  Pruszak, Jan ^a   Ludwig, Wesley ^a   Blak, Alexandra ^a   Alavian, Kambiz ^a   Isacson, Ole ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Brain tumors; Cell therapy; Epithelial mesenchymal transition; Flow cytometry; Neurons; Stem cells; Surface antigens; Transplantation

Indexed keywords

BETA1 INTEGRIN; CD15 ANTIGEN; CD24 ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; EMBRYONIC STEM CELL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MOUSE; NEURAL STEM CELL; NEUROBLAST; NONHUMAN; PHENOTYPE; STEM CELL;

ANIMALS; ANTIGENS, CD15; ANTIGENS, CD24; ANTIGENS, CD29; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CELL MEMBRANE; CELLS, CULTURED; FEMALE; FUCOSYLTRANSFERASES; HUMANS; MICE; MICE, INBRED C57BL; NEURONS; STEM CELLS;

EID: 73349120240     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.211     Document Type: Article

References (66)

1. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008;132(4):661-680.
2. Deb KD, Sarda K. Human embryonic stem cells: Preclinical perspectives. J Transl Med 2008;6:7.
3. Mountford JC. Human embryonic stem cells: Origins, characteristics and potential for regenerative therapy. Transfus Med 2008;18(1):1-12.
4. Bjorklund LM, Sanchez-Pernaute R, Chung S et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002;99(4):2344-2349.
5. Tabar V, Tomishima M, Panagiotakos G et al. Therapeutic cloning in individual parkinsonian mice. Nat Med 2008;14(4):379-381.
6. Wernig M, Zhao JP, Pruszak J et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A 2008;105(15):5856-5861.
7. Sonntag KC, Pruszak J, Yoshizaki T et al. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 2007;25(2):411-418.
8. Astradsson A, Cooper O, Vinuela A et al. Recent advances in cellbased therapy for Parkinson disease. Neurosurg Focus 2008;24(3-4):E6.
9. Roy NS, Cleren C, Singh SK et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 2006;12(11):1259-1268.
10. McKay R, Kittappa R. Will stem cell biology generate new therapies for Parkinson's disease? Neuron 2008;58(5):659-661.
11. Mendez I, Vinuela A, Astradsson A et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med 2008;14(5):507-509.
12. Mendez I, Sanchez-Pernaute R, Cooper O et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 2005;128(Pt 7):1498-1510.
13. Kordower JH, Chu Y, Hauser RA et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008;14(5):504-506.
14. Li JY, Englund E, Holton JL et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008;14(5):501-503.
15. Pruszak J, Sonntag KC, Aung MH et al. Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells 2007;25(9):2257-2268.
16. Brederlau A, Correia AS, Anisimov SV et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006;24(6):1433-1440.
17. Carson CT, Aigner S, Gage FH. Stem cells: The good, bad and barely in control. Nat Med 2006;12(11):1237-1238.
18. Li JY, Christophersen NS, Hall V et al. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci 2008;31(3):146-153.
19. Chung S, Shin BS, Hedlund E et al. Genetic selection of sox1GFPexpressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J Neurochem 2006;97(5):1467-1480.
20. Horan PK, Slezak SE, Poste G. Improved flow cytometric analysis of leukocyte subsets: simultaneous identification of five cell subsets using two-color immunofluorescence. Proc Natl Acad Sci U S A 1986;83(21):8361-8365.
21. Herzenberg LA, Parks D, Sahaf B et al. The history and future of the fluorescence activated cell sorter and flow cytometry: A view from Stanford. Clin Chem 2002;48(10):1819-1827.
22. Uchida N, Buck DW, He D et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000;97(26):14720-14725.
23. Ono Y, Nakatani T, Sakamoto Y et al. Differences in neurogenic potential in floor plate cells along an anteroposterior location: Midbrain dopaminergic neurons originate from mesencephalic floor plate cells. Development 2007;134(17):3213-3225.
24. Maric D, Barker JL. Neural stem cells redefined: A FACS perspective. Mol Neurobiol 2004;30(1):49-76.
25. Rietze RL, Valcanis H, Brooker GF et al. Purification of a pluripotent neural stem cell from the adult mouse brain. Nature 2001;412(6848):736-739.
26. Wernig M, Tucker KL, Gornik V et al. Tau EGFP embryonic stem cells: An efficient tool for neuronal lineage selection and transplantation. J Neurosci Res 2002;69(6):918-924.
27. Hedlund E, Pruszak J, Lardaro T et al. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 2008;26(6):1526-1536.
28. Ozdinler PH, Macklis JD. IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat Neurosci 2006;9(11):1371-1381.
29. Sundberg M, Jansson L, Ketolainen J et al. CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells. Stem Cell Res 2009;2(2):113-124.
30. Pruszak J, Isacson O. Directed differentiation of human embryonic stem cells into dopaminergic neurons. In: Sullivan S, Cowan C, Eggan K, eds. Human Embryonic Stem Cells: The Practical Handbook. New York: Wiley, 2007.
31. Lee SH, Lumelsky N, Studer L et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000;18(6):675-679.
32. Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448(7151):318- 324.
33. Pruszak J, Just L, Isacson O, Nikkhah O. Isolation and culture of ventral mesencephalic precursor cells and dopaminergic neurons. Current Protocols in Stem Cell Biology 2009, Unit 2D.04
34. Draper JS, Pigott C, Thomson JA et al. Surface antigens of human embryonic stem cells: Changes upon differentiation in culture. J Anat 2002;200(Pt 3):249-258.
35. Cui L, Johkura K, Yue F et al. Spatial distribution and initial changes of SSEA-1 and other cell adhesion-related molecules on mouse embryonic stem cells before and during differentiation. J Histochem Cytochem 2004;52(11):1447-1457.
36. Fox N, Damjanov I, Knowles BB et al. Immunohistochemical localization of the mouse stage-specific embryonic antigen 1 in human tissues and tumors. Cancer Res 1983;43(2):669-678.
37. Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A 1978;75(11):5565-5569.
38. Schmandt T, Meents E, Gossrau G et al. High-purity lineage selection of embryonic stem cell-derived neurons. Stem Cells Dev 2005;14(1):55-64.
39. Elkabetz Y, Panagiotakos G, Al SG et al. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev 2008;22(2):152-165.
40. Florek M, Haase M, Marzesco AM et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 2005;319(1):15-26.
41. Lee G, Kim H, Elkabetz Y et al. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol 2007;25(12):1468-1475.
42. Capela A, Temple S. LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1. Dev Biol 2006;291(2):300-313.
43. Wakimoto H, Kesari S, Farrell CJ et al. Human glioblastoma-derived cancer stem cells: Establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res 2009;69(8):3472-3481.
44. Unverzagt KL, Bender JG, Loudovaris M et al. Characterization of a culture-derived CD15+CD11b- promyelocytic population from CD34+ peripheral blood cells. J Leukoc Biol 1997;62(4):480-484.
45. Hess DA, Wirthlin L, Craft TP et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006;107(5):2162-2169.
46. Miki J, Furusato B, Li H et al. Identification of Putative Stem Cell Markers, CD133 And CXCR4, In hTERT-Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens. Cancer Res 2007;67(7):3153-3161.
47. Richardson GD, Robson CN, Lang SH et al. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004;117(Pt 16):3539-3545.
48. Hilbe W, Dirnhofer S, Oberwasserlechner F et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in nonsmall cell lung cancer. J Clin Pathol 2004;57(9):965-969.
49. Lathia JD, Rao MS, Mattson MP et al. The microenvironment of the embryonic neural stem cell: Lessons from adult niches? Dev Dyn 2007;236(12):3267-3282.
50. Allendoerfer KL, Durairaj A, Matthews GA et al. Morphological domains of Lewis-X/FORSE-1 immunolabeling in the embryonic neural tube are due to developmental regulation of cell surface carbohydrate expression. Dev Biol 1999;211(2):208-219.
51. Capela A, Temple S. LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron 2002;35(5):865-875.
52. Read TA, Fogarty MP, Markant SL et al. Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell 2009;15(2):135-147.
53. Ward RJ, Lee L, Graham K et al. Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma. Cancer Res 2009; 69(11):4682-4690.
54. Graus-Porta D, Blaess S, Senften M et al. Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 2001;31(3):367-379.
55. Hall PE, Lathia JD, Miller NG et al. Integrins are markers of human neural stem cells. Stem Cells 2006;24(9):2078-2084.
56. Breau MA, Pietri T, Eder O et al. Lack of beta1 integrins in enteric neural crest cells leads to a Hirschsprung-like phenotype. Development 2006;133(9):1725-1734.
57. Fuchs BC, Fujii T, Dorfman JD et al. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 2008;68(7):2391-2399.
58. Miller FD. Riding the waves: Neural and nonneural origins for mesenchymal stem cells. Cell Stem CELL 2007;1(2):129-130.
59. Takashima Y, Era T, Nakao K et al. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007;129(7):1377-1388.
60. Nieoullon V, Belvindrah R, Rougon G et al. mCD24 regulates proliferation of neuronal committed precursors in the subventricular zone. Mol Cell Neurosci 2005;28(3):462-474.
61. Zola H. Medical Applications of Leukocyte Surface
62. Mani SA, Guo W, Liao MJ et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133(4):704-715.
63. Sun Y, Kong W, Falk A et al. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. Plos One 2009;4(5):e5498.
64. Lazzari G, Colleoni S, Giannelli SG et al. Direct derivation of neural rosettes from cloned bovine blastocysts: A model of early neurulation events and neural crest specification in vitro. Stem Cells 2006;24(11):2514-2521.
65. Barberi T, Bradbury M, Dincer Z et al. Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 2007;13(5):642-648.
66. Kosodo Y, Roper K, Haubensak W et al. Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells. Embo J 2004;23(11):2314-2324.